ArticleCancer gene therapy2024

The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model.

Soon Cheon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.